AKAO: Achaogen Holder Growth Equity Reports 19.9% Stake
Achaogen (AKAO) raised to outperform at Wedbush
12:40 pm Sohn Conf winner on CNBC - he has a SHORT piece & a $20 price tgt on the name
Origin Technologies offered ~$1.5b to buy medical technology company Affymetrix, topping a bid from Thermo Fisher Scientific.
• Origin Technologies offers $1.5b or $16.10 a share, 15% more than Thermo Fisher’s $1.3b bid in Jan.
appears another Neostig may have been approved
Right, they dont want to sell and and make revenues to someone who wants to buy ~ very smart